Diagnostic Substances Industry
Hot Stocks in This Industry
Sector
Related Industries
Stocks in Diagnostic Substances Sector
ABAXIS
AMAG Pharmaceuticals
BIOMODA
BURZYNSKI RESEARCH
CHEMBIO DIAGNOSTICS
CORGENIX MED
Icagen
IMARX THERAPEUTICS
Immucor
Infinity Pharmaceuticals
LIFEVANTAGE
Myriad Genetics
Nymox Pharmaceutical
Orchid Cellmark
Pressure BioSciences
Raptor Pharmaceutical
RG GLBL LIFESTYLS
SANGUINE
SurModics
Trinity Biotech plc
AMAG Pharmaceuticals
BIOMODA
BURZYNSKI RESEARCH
CHEMBIO DIAGNOSTICS
CORGENIX MED
Icagen
IMARX THERAPEUTICS
Immucor
Infinity Pharmaceuticals
LIFEVANTAGE
Myriad Genetics
Nymox Pharmaceutical
Orchid Cellmark
Pressure BioSciences
Raptor Pharmaceutical
RG GLBL LIFESTYLS
SANGUINE
SurModics
Trinity Biotech plc
Akorn
AspenBio Pharma
BRAINSTORM CELL THER
Celldex Therapeutics
CNS RESPONSE, INC.
HEMAGEN DIAG
IDEXX Laboratories
ImmuCell
Immunomedics
Interleukin Genetics
Meridian Bioscience
Neogen
OncoGenex Pharmaceuticals
Palatin Technologies
Quidel
Response Genetics
Rosetta Genomics
SCOLR
Synta Pharmaceuticals
AspenBio Pharma
BRAINSTORM CELL THER
Celldex Therapeutics
CNS RESPONSE, INC.
HEMAGEN DIAG
IDEXX Laboratories
ImmuCell
Immunomedics
Interleukin Genetics
Meridian Bioscience
Neogen
OncoGenex Pharmaceuticals
Palatin Technologies
Quidel
Response Genetics
Rosetta Genomics
SCOLR
Synta Pharmaceuticals
Diagnostic Substances Upgrades
Diagnostic Substances Downgrades
Diagnostic Substances New Coverages
Diagnostic Substances Earnings
Date
Company
Actual
Expected
Prev Yr Qtr
Special Offers
On This Date
December 30, 1999:
The Nasdaq closed above 4,000 for the first time less than two months after its first close above 3,000. It ended up 84% for the year overall.
The Nasdaq closed above 4,000 for the first time less than two months after its first close above 3,000. It ended up 84% for the year overall.
Research Assistant
How to use this tool



How to use this tool





